Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease

Published:2019-10-21 Issue:3 Volume:71 Page:907-916
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Yang Ju Dong¹²³⁴,Ahmed Fowsiyo¹,Mara Kristin C.⁵,Addissie Benyam D.⁶,Allen Alina M.¹^ORCID,Gores Gregory J.¹,Roberts Lewis R.¹

Affiliation:

1. Division of Gastroenterology and Hepatology Mayo Clinic College of Medicine and Science Rochester MN

2. Division of Digestive and Liver Diseases, Department of Internal Medicine Cedars‐Sinai Medical Center Los Angeles CA

3. Comprehensive Transplant Center Cedars Sinai Medical Center Los Angeles CA

4. Samuel Oschin Comprehensive Cancer Institute Cedars Sinai Medical Center Los Angeles CA

5. Department of Health Science Research Mayo Clinic College of Medicine and Science Rochester MN

6. Division of Gastroenterology and Hepatology Geisinger Medical Center Danville PA

Funder

National Cancer Institute

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30858

Reference41 articles.

1. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study

2. Recent Trends in the Epidemiology of Hepatocellular Carcinoma in Olmsted County, Minnesota

3. Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005

4. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

5. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

Cited by 148 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostics and omics technologies for the detection and prediction of metabolic dysfunction-associated steatotic liver disease-related malignancies;Metabolism;2024-12

2. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

3. Lower hepatocellular carcinoma surveillance in metabolic dysfunction‐associated steatotic liver disease: Impact on treatment eligibility;Journal of Gastroenterology and Hepatology;2024-08-27

4. Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies;Journal of the Canadian Association of Gastroenterology;2024-08-09

5. Effects of weight loss from oral semaglutide administration on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a retrospective analysis using propensity score matching;Diabetology International;2024-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3